Rate My Professor Mark Wheatley
Ratings & reviews
Always patient and willing to help.
This comment is not public.
Taught by or worked with Mark?
Add your rating. It takes about 30 seconds.
About Mark
Professor Mark Wheatley is Professor of Biochemical Pharmacology at Coventry University, appointed in 2018, and serves as Lead for the Pharmacology and Molecular Bioscience Research Theme within the Centre for Health and Life Sciences. He is also a Professor in the Centre for Discoveries in Life Sciences. At the University of Birmingham, he began his academic career as a Lecturer in 1988, was promoted to Chair in Biochemical Pharmacology in 2007, and holds an Honorary Professorship since 1 December 2018. Possessing over 30 years of experience, Wheatley's research specializations centre on the structure and function of G-protein-coupled receptors (GPCRs), investigated through multi-disciplinary approaches. His contributions include developing detergent-free solubilisation and purification techniques for membrane proteins, notably using styrene-maleic acid lipid particles (SMALPs). He explores ligand binding and activation mechanisms, receptor interactions such as those with Receptor Activity-Modifying Proteins (RAMPs) and CRF receptors, and structural studies of GPCRs and other membrane proteins within lipid nanoparticles.
Wheatley has built an international reputation, collaborating with multinational pharmaceutical companies due to the therapeutic relevance of his GPCR research. He was elected Fellow of the British Pharmacological Society in 2016. His prolific output encompasses 112 research items, including 83 articles, 14 conference contributions, 6 reviews, and 3 book chapters, amassing 2954 citations and an h-index of 32. Key publications include 'GPCRs in the round: SMA-like copolymers and SMALPs as a platform for investigating GPCRs' (Archives of Biochemistry and Biophysics, 2024), 'Tunable Terpolymer Series for the Systematic Investigation of Membrane Proteins' (Biomacromolecules, 2024), 'Long-Circulating Vasoactive 1,18-Octadecanedioic Acid–Terlipressin Conjugate' (ACS Pharmacology and Translational Science, 2024), and 'Doxorubicin increases G-protein coupled receptor-mediated vasoconstriction in coronary arteries via the mitogen-activated protein kinase kinase 1/2 pathway' (European Journal of Pharmacology, 2025). He edited 'G Protein-Coupled Receptors: Essential Methods' (2010) and has secured funding from BBSRC and Wellcome Trust for GPCR-related projects. Wheatley accepts PhD students.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash